Biomarkers associated with nephropathy
Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
1. A method of detecting, in a urine sample, the level of a fragment of leukocyte-associated Ig-like receptor-2 consisting of the sequence of SEQ ID NO:1, wherein the detecting step is performed with an immune assay.
2. The method of claim 1 , wherein the immune assay is Western blot, ELISA, radioimmunoassay (RIA), fluorescent immunoassay (FIA), or luminescence immunoassay (LIA).
3. The method of claim 1 , wherein the urine sample is obtained from a human subject.
4. The method of claim 1 , wherein the urine sample is obtained from a laboratory animal.